Patient Dies in Bristol Myers Squibb Autoimmune CAR-T Trial
A patient has died during a clinical trial of the investigational CAR-T therapy zolacabtagene autoleucel for multiple sclerosis.
Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made
The story so far
2 publishers have covered this in 2 articles since 23 Oct 2026. STAT published first, on 23 October at 18:55 UTC; MedPageToday.com - medical news for physicians followed 24h 24m later. The most recent article, from MedPageToday.com - medical news for physicians, appeared on 24 October at 19:19 UTC.
Outlets reporting it: STAT, MedPageToday.com - medical news for physicians.
No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.
Sources
Every article we clustered into this story. Headlines link to the publisher.
In this story
- Bristol Myers Squibb